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Abstract
The purinergic P2X7 receptor (P2X7R) is a sensor of extracellular ATP, a damage-associated molecule that is released from
necrotic cells and that induces pro-inflammatory cytokine production and cell death. To investigate whether the innate
immune response to damage signals could contribute to the development of pulmonary necrotic lesions in severe forms of
tuberculosis, disease progression was examined in C57BL/6 and P2X7R2/2 mice that were intratracheally infected with
highly virulent mycobacterial strains (Mycobacterium tuberculosis strain 1471 of the Beijing genotype family and
Mycobacterium bovis strain MP287/03). The low-dose infection of C57BL/6 mice with bacteria of these strains caused the
rapid development of extensive granulomatous pneumonia with necrotic areas, intense bacillus dissemination and
anticipated animal death. In contrast, in P2X7R2/2 mice, the lung pathology presented with moderate infiltrates of
mononuclear leukocytes without visible signs of necrosis; the disease attenuation was accompanied by a delay in mortality.
In vitro, the hypervirulent mycobacteria grew rapidly inside macrophages and induced death by a P2X7R-dependent
mechanism that facilitated the release of bacilli. Furthermore, these bacteria were resistant to the protective mechanisms
elicited in macrophages following extracellular ATP stimulation. Based on this study, we propose that the rapid intracellular
growth of hypervirulent mycobacteria results in massive macrophage damage. The ATP released by damaged cells engages
P2X7R and accelerates the necrotic death of infected macrophages and the release of bacilli. This vicious cycle exacerbates
pneumonia and lung necrosis by promoting widespread cell destruction and bacillus dissemination. These findings suggest
the use of drugs that have been designed to inhibit the P2X7R as a new therapeutic approach to treat the aggressive forms
of tuberculosis.
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Introduction
Tuberculosis (TB) is a serious public health issue, with nearly 9
million new annual cases of the disease worldwide and 1.3 million
deaths per year [1]. A third of the global population is infected
with bacteria of the Mycobacterium tuberculosis complex (Mycobacterium
tuberculosis – Mtb and Mycobacterium bovis – Mbv), although most
effectively control the pathogen and remain asymptomatic by
establishing equilibrium with the bacilli [2]. Mycobacteria are
typically transmitted by aerosols and reach the lungs, where
macrophages and other immune cells are recruited during the
early innate response to infection. The latent infection results from
the equilibrium between mycobacteria and the host defenses, in
which inflammatory cells become organized as primary granulo-
mas.
The reactivation of latent infections in immunocompetent
individuals occurs at rates that range from 3% to 10% per lifespan
[3]; these rates are dramatically increased by co-infection with the
human immunodeficiency virus (HIV) [4]. Accelerations in active
TB reactivations have also been described after the administration
of tumor necrosis factor (TNF)a/IL-12/IL-23 blockers, which are
used to treat inflammatory diseases, such as rheumatoid arthritis
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and Crohn’s disease [2,5]. Progressive primary TB is an
alternative form of the disease that represents less than 10% of
active TB cases in normal adults, although it is common in
children less than 5 years of age and in immunocompromised
individuals [6]. The aggressive forms of mycobacterial infections
are characterized by the rapid expansion of primary granuloma-
tous infiltrates in the lungs that results in tuberculous pneumonia
and disseminated disease, such as miliary TB pneumonia. The
precipitation of TB pathology is hallmarked by the formation of
central caseous necrotic lesions filled with extracellular infectious
bacilli and cell debris [7]. The factors that determine the transition
of mycobacterial infections to active TB and the rapid progression
of the disease have not been fully elucidated. The characteristics of
the bacteria (i.e., high bacterial virulence or high dose of infection)
and the host (i.e., genetic predisposition, immunodeficiency or
malnutrition) are thought to contribute to progression of the
disease [8].
Mouse TB models have been extremely useful in the
characterization of mechanisms that are involved in disease
pathogenesis and the generation of protective immunity. However,
it is difficult to determine the factors that are responsible for the
development of pulmonary necrosis because this process is atypical
in mice that are infected with virulent mycobacteria, such as the
H37Rv reference strain [7]. Necrotic lesions occur mostly in mice
that are deficient in immunologically relevant molecules, such as
inducible nitric oxide synthase (iNOS), the T cell receptor
(TCR)ab, interferon (IFN)c, the TNF receptor (TNFR)-1, IL-6
and IL-12 [9]. Mice deficient in IL-1R1, IL-6, IL-10, CD4, CD8
or c/d T cells present with discrete pulmonary intragranuloma-
tous necrosis. Alternatively, artificial conditions are required to
induce necrosis in mice, such as intraperitoneal infections with
extremely high numbers of bacilli [10] or intranasal infections with
a low bacillus inoculum, followed by the administration of
lipopolysaccharide (LPS) or polyinosinic-polycytidylic acid
(Poly-IC) [9,11,12]. Moreover, dermal infections of iNOS-
deficient mice lead to the formation of non-necrotizing granulo-
mas in the lungs, which exhibit central caseation and hypoxia
when IFNc or TNFa are blocked [13].
Recent epidemiologic studies have shown that Mtb strains
belonging to the emerging Beijing genotype family, which are
associated with high virulence, transmissibility and drug resistance
[14], are more likely to cause rapid progression of the primary
infection to active TB than the strains belonging to other genotype
groups [15]. Highly virulent Beijing strains, in contrast to the less
virulent strains of Beijing or non-Beijing Mtb genotypes, promote
unusual rapid fatal diseases in infected mice that are characterized
by a severe pulmonary pathology, with high bacterial burden and
extensive lung consolidation and areas of focal necrosis [16,17,18].
Furthermore, infections of mice with few Mbv strains are able to
cause sudden pneumonia with extensive necrosis that lead to early
death [19]. Studies with mice infected with hypervirulent
mycobacterial strains suggest a possible method for investigating
the specifics of the immunopathogenesis behind the aggressive
forms of TB. An elucidation of the molecular mechanisms that are
implicated in the development of severe TB is important to
elaborate new therapeutic strategies.
Necrotic cell death permits the release of damage-associated
molecular patterns (DAMPs), such as adenosine triphosphate
(ATP). Extracellular ATP (eATP) is a danger signal for cells of the
immune system and contributes to inflammatory and reparatory
responses [20,21,22]. ATP is also released by activated and
apoptotic cells through pannexin-1 hemichannels, which results in
autocrine and paracrine cell signaling [23]. Some compelling
evidence indicates that eATP levels increase in vivo to concentra-
tions greater than 100 mM during pathological processes [24,25].
Among the purinergic P2 receptors that recognize eATP, the
P2X7 receptor (P2X7R) is uniquely able to induce pro-inflam-
matory cytokine production and cell death [26,27,28]. Therefore,
eATP recognition by P2X7R contributes to the development of
sterile and infectious inflammation in different experimental
models [21,22,28,29,30]. The altered intracellular ionic milieu
that results from P2X7R activation presumably triggers the
nucleotide-binding domain and leucine-rich repeat-containing
gene family pyrin domain-containing 3 protein (NLRP3) inflam-
masome, which leads to the pro-inflammatory cytokine production
and apoptotic cell death [31,32,33]. The prolonged stimulation of
P2X7R permits the formation of large transmembrane pores and
the flux of molecules between 314 and 900 Da [26]. Depending on
the magnitude and duration of the stimulus, the predominance of
each of these molecular pathways dictates the development of
apoptotic or necrotic cell death [34]. The combined activation of
different molecular pathways culminates in pyroptosis, pyrone-
crosis or damaged mitochondria-dependent necroptosis [35].
Based on these findings, we were determined to investigate
whether the recognition of eATP from necrotic cells by P2X7R
could elicit an innate immune response and contribute to the
development of severe TB. To investigate this possibility, we used
murine models of pulmonary TB induced by intratracheal
infections with the highly virulent isolates Mtb strain 1471 (Beijing
genotype) and Mbv strain MP287/03. These mycobacterial strains
were epidemiologically associated with outbreaks of TB in human
and bovine populations, respectively, and showed high virulence in
our previous in vitro studies [36,37,38]. In C57BL/6 mice that were
infected with a low dose (approx. 100 bacilli) of hypervirulent
mycobacteria, we reproduced several pathological manifestations
of the aggressive forms of human TB, including tuberculous
pneumonia with areas of focal necrosis and miliary dissemination
to the liver and spleen. We then examined the courses of infection,
Author Summary
Nearly 9 million new cases of tuberculosis and 1.3 million
deaths are reported yearly worldwide. Most individuals
infected with tubercle bacilli remain asymptomatic; how-
ever, some develop active tuberculosis due to the
reactivation of latent infections. Progressive primary
tuberculosis is an alternative form of the disease that
mostly affects children and immunocompromised individ-
uals. Extensive pneumonia, pulmonary necrosis and
bacillus dissemination characterize some of the aggressive
forms of tuberculosis. To investigate the molecular
mechanisms that underlie severe disease progression, we
used experimental models of relatively resistant C57BL/6
mice that were infected with highly virulent strains of
Mycobacterium tuberculosis or Mycobacterium bovis. Two
hypervirulent strains (Mtb strain 1471 and Mbv strain
MP287/03) induced extensive pulmonary inflammation
and necrosis in mice and promoted bacillus dissemination
and animal death. We hypothesized that the innate
immune response to endogenous damage signals from
necrotic cells could aggravate the disease. We focused our
study on the purinergic P2X7 receptor (P2X7R), a sensor of
ATP that is released from necrotic cells and that induces
pro-inflammatory cytokine production and cell death. Our
data provide new insights into the pathogenesis of severe
tuberculosis by showing that mice that lack P2X7R have
attenuated disease with substantially reduced bacillus
dissemination and lung inflammation without evidence of
necrosis.
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lung pathologies and bacterial burdens in P2X7R2/2 and
C57BL/6 mice. Our data provide new insights into the
pathogenesis of severe TB by showing a requirement for P2X7R
in the induction of macrophage death and the progression of
tuberculous pneumonia, necrotic pulmonary lesions, bacillus
dissemination and anticipated animal death.
Results
Severe TB caused by hypervirulent Beijing 1471 Mtb and
MP287/03 Mbv is attenuated in P2X7R-deficient mice
Because ATP released from necrotic cells activates P2X7R and
subsequently the innate immune response [23,26,27], we won-
dered if this molecular pathway may contribute to the develop-
ment of the aggressive forms of TB that are associated with intense
pulmonary necrosis. To investigate this possibility, two hypervir-
ulent Mtb and Mbv strains were selected from 9 strains (Mtb –
zt272, 1471 (genotype Beijing), 1777 (genotype LAM) and H37Rv;
Mbv – AN5, B2, B29, MP287/03 and MP389/03) on the basis of
the ability to induce severe TB, i.e., intense pulmonary infiltration
with lung necrosis and precocious death of C57BL/6 mice that
were infected intratracheally (i.t.) with low doses of bacilli (approx.
100 forms). Beijing 1471 Mtb and MP287/03 Mbv exhibited
higher virulence within each subgroup (Mtb and Mbv) compared to
the other strains (data not shown). The diseases induced by these
strains in C57BL/6 and P2X7R2/2 mice were compared to those
induced by the virulent H37Rv Mtb strain, which did not induce
pulmonary necrosis in C57BL/6 mice. A previous study in
P2X7R2/2 mice reported no involvement of the P2X7R during
pulmonary H37Rv Mtb infection [39], whereas another study
described a protective role for this receptor [40].
Our results show that infection with Beijing 1471 Mtb killed
90% of C57BL/6 mice until 250 days post-infection (p.i.), whereas
MP287/03 Mbv induced 100% mortality before day 40 p.i.
(Figure 1A). Remarkably, all of the P2X7R2/2 mice infected with
Beijing 1471 Mtb remained alive throughout this period, and the
survival time was considerably increased when these animals were
infected with MP287/03 Mbv. For the H37Rv Mtb infection,
100% survival was observed in C57BL/6 and P2X7R2/2 groups.
The bacillus counts in the lungs of C57BL/6 mice at day 28 p.i.
with Beijing 1471 Mtb and MP287/03 Mbv (CFU Log10 6.760.2
and 8.860.2, respectively) were approximately 10-fold and 1,000-
fold higher, respectively, than those in mice infected with H37Rv
Mtb (CFU Log10 5.860.4) (Figure 1B). Furthermore, the
P2X7R2/2 mice infected with hypervirulent mycobacteria
showed a nearly 10-fold reduction of lung bacillary burden
compared to the C57BL/6 counterparts. In contrast, similar
CFU values were obtained for the lungs of the C57BL/6 and
P2X7R2/2 mice infected with H37Rv Mtb. Moreover, the disease
dissemination to the liver and spleen was attenuated in P2X7R2/2
mice infected with hypervirulent mycobacteria, whereas no
significant difference was found between C57BL/6 and
P2X7R2/2 mice infected with H37Rv Mtb.
P2X7R mediates pneumonia and lung necrosis in mice
infected with hypervirulent mycobacteria
To further characterize the effects of P2X7R during severe TB
caused by hypervirulent mycobacteria, pneumonia and lung
necrosis were evaluated in C57BL/6 and P2X7R2/2 mice on
day 28 p.i. with the Beijing 1471 Mtb, MP287/03 Mbv and H37Rv
Mtb strains. Macroscopically, the lungs had white nodules that
were more prominent in C57BL/6 mice infected with hypervir-
ulent mycobacteria (Figure 2A). Furthermore, the lung weights
and relative masses were greatest in C57BL/6 mice infected with
MP287/03 Mbv, followed by those infected with Beijing 1471 Mtb
(Figures 2B and 2C). Considerably smaller white nodules were
observed in the lungs of P2X7R2/2 mice that were infected with
either hypervirulent strain, and these lungs were observed to have
lower weights and relative masses. The lung weights in C57BL/6
and P2X7R2/2 mice infected with H37Rv Mtb did not statistically
differ from those in non-infected controls.
Microscopically, the lungs of C57BL/6 and P2X7R2/2 mice
infected with H37Rv Mtb presented with incipient granulomas
with no visible acid-alcohol resistant bacillus (BAAR) (Figures 3A–
B and 3C–D, respectively). Additionally, comparable reductions of
nearly 20% in the areas of lung sections covered by intralveolar
spaces were observed in C57BL/6 and P2X7R2/2 mice infected
with H37Rv Mtb (Figure 3M). In contrast, extensive cellular
infiltrations in the lung tissues and intralveolar spaces, accompa-
nied by granuloma formation with necrotic lesions and BAARs,
were observed in C57BL/6 mice infected with Beijing 1471 Mtb
(Figures 3E and 3F) and MP287/03 Mbv (Figures 3I and 3J).
Remarkably, reduced areas of inflammation and necrosis
with lower numbers of BAARs were observed in the lungs of
P2X7R2/2 mice infected with both hypervirulent strains
(Figures 3G–H and 3K–L). Accordingly, C57BL/6 mice infected
with Beijing 1471 Mtb and MP287/03 Mbv showed sharp
decreases of over 80% in the areas of lung sections occupied by
intralveolar spaces, a phenomenon that was drastically attenuated
in the P2X7R2/2 counterparts (Figure 3M).
P2X7R mediates the recruitment of myeloid cells to the
lungs in mice infected with hypervirulent mycobacteria
To determine the mechanisms by which the P2X7R detrimen-
tally affects the outcome of severe TB, we next examined whether
the lack of P2X7R modifies the pulmonary influx of leukocytes
and the cytokine profile. We evaluated IL-1b production because
it can be induced following P2X7R activation. We also examined
IFNc and IL-10 production because these cytokines have
counterbalancing effects on inflammatory processes. These three
cytokines have important roles in pulmonary TB [9,13,41].
In agreement with the macro- and microscopic analysis of the
lungs, C57BL/6 mice infected with Beijing 1471 Mtb and MP287/
03 Mbv presented on day 28 p.i. with high numbers of lung
infiltrating cells that were significantly reduced in P2X7R2/2
counterparts (Figure 4A). For the H37Rv Mtb infection, the total
cell numbers in the lungs of C57BL/6 mice were similar to those
of P2X7R2/2 mice and were 2- to 3-fold lower than those
induced by hypervirulent strains. Unexpectedly, the composition
of cellular infiltrates differed between the two groups of C57BL/6
mice infected with hypervirulent strains. Pulmonary myeloid
(CD11b+ cells) and lymphoid (CD19+, CD4+ and CD8+ cells)
subsets were found in similar proportions in Beijing 1471 Mtb-
infected C57BL/6 mice. In contrast, a strong predominance of
CD11b+ cells with virtually no T and B cells was observed in
MP287/03 Mbv-infected C57BL/6 mice. The absence of P2X7R
led to reduced pulmonary infiltration of myeloid cells in both
hypervirulent infections and reduced lymphoid cells in the
Beijing 1471 Mtb infection. However, MP287/03 Mbv-infected
P2X7R2/2 mice presented with higher numbers of CD4+ and
CD8+ cells compared to their C57BL/6 counterparts. C57BL/6
and P2X7R2/2 mice infected with H37Rv Mtb showed compa-
rable numbers of pulmonary myeloid and lymphoid subsets. The
CD11b+ population was mostly composed of Ly6C+ cells
(monocytes) in all of the infected mice, with the exception of
MP287/03 Mbv-infected C57BL/6 mice, which showed a
predominance of Ly6G+ cells (neutrophils) (data not shown,
manuscript in preparation).
The Role of P2X7 Receptor in Severe Tuberculosis
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The profiles of cytokines produced by lung infiltrating cells
also varied between the two groups of C57BL/6 mice on day 28
p.i. with hypervirulent strains; relatively high or low production
levels of pro-inflammatory cytokines were observed during
severe TB (Figure 4B). More precisely, cells from Beijing 1471
Mtb-infected C57BL/6 mice produced higher levels of IL-1b
and IFNc. In contrast, cells from MP287/03 Mbv-infected mice
secreted comparatively lower levels of pro-inflammatory cyto-
kines and higher levels of IL-10, which supports the notion that
MP287/03 Mbv is a poor inducer of pro-inflammatory cytokines
[38]. As observed for the composition of cellular infiltrates, the
absence of P2X7R had different effects on the cytokine profiles
induced by hypervirulent strains. For the Beijing 1471 Mtb
infection, cells from P2X7R2/2 mice secreted significantly
reduced amounts of IL-1b and IFNc and increased amounts
of IL-10 compared to cells from C57BL/6 mice. For the
MP287/03 Mbv infection, comparable low levels of IL-1b were
found in cell supernatants from C57BL/6 and P2X7R2/2 mice,
but the lack of P2X7R resulted in an increase of IFNc and a
decrease of IL-10. The H37Rv Mtb infection induced very low
production of IL-1b, IFNc and IL-10; the amount of
pro-inflammatory cytokines was significantly reduced in the
absence P2X7R.
Hypervirulent mycobacteria induce macrophage necrosis
by a P2X7R-mediated mechanism
The following experiments were performed to further elucidate
the mechanisms that are responsible for the deleterious role of
P2X7R in severe TB. The intracellular bacterial growth and
dissemination were investigated in bone marrow-derived macro-
phages (BMDMs) obtained from C57BL/6 and P2X7R2/2 mice
that were infected with H37Rv Mtb, Beijing 1471 Mtb and
MP287/03 Mbv strains. The analysis was performed over a
maximum period of 6 days in culture after macrophage
differentiation, during which the viability of non-infected BMDMs
was maintained above 95%. The intracellular bacterial growth
was evaluated at an MOI (multiplicity of infection) of 1, which
ensured bacillus multiplication for 6 days p.i. in the absence of
spontaneous and bacillus-induced macrophage death. The low
MOI was particularly important for hypervirulent mycobacterial
strains that grew rapidly and killed the macrophages. The
macrophage necrosis induced by the mycobacteria was
Figure 1. Survival curves and bacillary burdens in the lungs, liver and spleen of C57BL/6 and P2X7R2/2 mice infected with
hypervirulent mycobacteria. C57BL/6 and P2X7R2/2 mice were infected i.t. with approx. 100 bacilli of H37Rv Mtb, Beijing 1471 Mtb and MP287/03
Mbv. Non-infected mice were used as controls. (A) The infected mice were examined daily to determine the survival curves (n = 13–19). (B) The
number of CFU/g of tissue was evaluated in the left lung, liver and spleen on day 28 p.i. (means6 SD, n = 9). Significant differences were observed for
the indicated groups (*p,0.05, **p,0.01 and ***p,0.001). The data are representative of three separate experiments.
doi:10.1371/journal.ppat.1004188.g001
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systematically determined at MOIs of 10 and 20; the best
conditions to discriminate C57BL/6 and P2X7R2/2 BMDMs are
shown.
The hypervirulent mycobacterial strains multiplied inside
C57BL/6 BMDMs much faster than did H37Rv Mtb and were
the most effective strains for inducing cell death (Figure S1A and
S1B). In an experimental condition of low bacillus-induced
macrophage death, P2X7R did not interfere with intracellular
bacterial growth; the growth kinetics of the mycobacterial strains
within C57BL/6 and P2X7R2/2 BMDMs were similar at an
MOI of 1 (Figure S1A). Remarkably, negligible numbers of
necrotic P2X7R2/2 BMDMs were observed on day 4 p.i. with
hypervirulent mycobacteria at an MOI of 10, an experimental
condition that induced C57BL/6 BMDM death (Figures 5A and
5B). The kinetics of cellular viability at an MOI of 20 showed
that the lack of P2X7R protected the BMDMs from early death,
but the Beijing 1471 Mtb infection killed C57BL/6 and
P2X7R2/2 BMDMs on day 6 p.i. (Figure S1B). Our data also
show that P2X7R-mediated necrosis of macrophages facilitates
the release of hypervirulent mycobacteria; more viable Beijing
1471 Mtb and MP287/03 Mbv bacilli were detected in the
supernatants of C57BL/6 BMDMs compared to those of
P2X7R2/2 BMDMs (Figure 5C). Supporting the idea that
Beijing 1471 Mtb and MP287/03 Mbv infections induce
macrophage necrosis, the majority of dead cells on day 4 p.i.
with hypervirulent strains were stained with PI but not with
annexin V (Figure S2). Furthermore, in accordance with the in
vivo data (Figure 4B), P2X7R2/2 BMDMs that were infected
with Beijing 1471 Mtb produced lower levels of IL-1b than did
the counterpart C57BL/6 BMDMs (Figure 5D). MP287/03 Mbv
was a poor inducer of IL-1b production in C57BL/6 BMDMs,
and this cytokine was not detected in the supernatants
from P2X7R2/2 BMDMs. The infection of C57BL/6 and
P2X7R2/2 BMDMs with H37Rv Mtb caused negligible
macrophage death (Figure 5A), extracellular release of the
bacilli (Figure 5C) and IL-1b production (Figure 5D), which
were not influenced by the P2X7R.
For hypervirulent strains but not for H37Rv Mtb, eATP
stimulation causes a P2X7R-mediated release of viable
mycobacteria by infected macrophages
Previous studies show that engagement of the P2X7R promotes
phagosome-lysosome fusion and induces apoptosis, thereby
causing intracellular mycobacterial killing [42,43,44]. In agree-
ment with the protective role of the P2X7R against mycobacterial
infection, macrophages from subjects homozygous for loss-of-
function P2X7R polymorphisms exhibit ablated eATP-induced
apoptosis and killing of mycobacteria [45,46,47]. As these analyses
were performed with BCG, an avirulent Mbv strain, the apparent
contrast between the protective role of P2X7R reported in these
studies and the deleterious role of P2X7R described here may
reside in the varying virulence of mycobacteria. If this is the case,
eATP stimulation of the P2X7R may have different consequences
in macrophages infected with virulent or hypervirulent strains,
causing mycobacterial killing or dissemination, respectively. To
examine this possibility, the numbers of intracellular and
extracellular bacilli were determined in P2X7R2/2 and
C57BL/6 BMDMs that were infected with H37Rv Mtb, Beijing
1471 Mtb and MP287/03 Mbv strains and then stimulated with
eATP. The protocol used in these experiments was similar to those
employed in the previous in vitro analyses described above
[45,46,47].
The activation of H37Rv Mtb-infected C57BL/6 BMDMs with
1 and 5 mM eATP led to P2X7R-mediated decreases in the
numbers of intracellular bacilli and no increase in the numbers of
extracellular bacilli (Figures 6A and 6B). At 1 mM eATP,
macrophage activation rather than apoptosis may determine the
P2X7R-mediated killing of H37Rv Mtb. At this eATP concentra-
tion, C57BL/6 BMDMs exhibited a typical morphology of viable
macrophages (Figure 6C). In contrast, at 5 mM eATP, the
protective effect was associated with a high level of death of
H37Rv Mtb-infected C57BL/6 BMDMs. Indeed, most C57BL/6
BMDMs presented with a necrotic phenotype at concentrations
greater than 3 mM eATP (Figure S3). As expected, P2X7R2/2
BMDMs were resistant to eATP-induced death. For hypervirulent
Figure 2. Lung gross pathology in C57BL/6 and P2X7R2/2 mice on day 28 p.i. with hypervirulent mycobacteria. C57BL/6 and P2X7R2/2
mice were infected i.t. with approx. 100 bacilli of H37Rv Mtb, Beijing 1471 Mtb and MP287/03 Mbv. Non-infected mice were used as controls. (A)
Representative images of the right lungs are shown. (B) Right lung weights and (C) relative masses (circles) were evaluated (n = 9). The mean values
are represented by horizontal lines. The relative lung masses were calculated by the ratios of the mean values of the lung weights in the indicated
groups and the control group. Significant differences were observed for the indicated groups (**p,0.01 and ***p,0.001). The data are representative
of three separate experiments.
doi:10.1371/journal.ppat.1004188.g002
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strains, the effects of eATP stimulation on C57BL/6 BMDMs
were completely different than they were for the H37Rv Mtb
strain. At 1 mM eATP, the numbers of intracellular and
extracellular bacilli showed minor or no changes for both the
Beijing 1471 Mtb and MP287/03 Mbv strains (Figures 6A and 6B).
At 5 mM eATP, the P2X7R-mediated decrease in the amount of
intracellular bacilli was associated with macrophage death
(Figure 6C). Most importantly, significantly higher numbers of
viable mycobacteria were detected in the supernatants of C57BL/
6 BMDMs infected with the Beijing 1471 Mtb and MP287/03 Mbv
strains (Figure 6B). The release of viable mycobacteria was
mediated by the P2X7R, which indicated that macrophages had
undergone P2X7R-mediated necrotic death. These results cor-
roborate our supposition that eATP stimulation of infected
macrophages has opposite consequences for virulent and hyper-
virulent strains. In other words, the heterogeneity of mycobacterial
Figure 3. Lung histopathology in C57BL/6 and P2X7R2/2 mice on day 28 p.i. with hypervirulent mycobacteria. C57BL/6 and P2X7R2/2
mice were infected i.t. with approx. 100 bacilli of H37Rv Mtb, Beijing 1471 Mtb and MP287/03 Mbv. (A–L) Images show representative lung sections
stained with HE (506magnification; bar scales correspond to 400 mm) and ZN (4006magnification; bar scales correspond to 50 mm) methods. (A and
C) H37Rv Mtb-infected C57BL/6 and P2X7R2/2 mice exhibited incipient granulomas. (B and D) Amplification of the inflamed areas shows no visible
BAAR in the mice presented in B and D. (E and I) Beijing 1471 Mtb- and MP287/03 Mbv-infected C57BL/6 mice displayed extensive lung TB lesions
with areas of necrosis. (F and J) Numerous BAARs were observed in the lesions described in E and I. (G and K) Beijing 1471 Mtb- and MP287/03 Mbv-
infected P2X7R2/2 mice presented with small lung lesions with no visible necrosis. (H and L) Reduced amounts of BAARs were observed in the lesions
described in G and K. (M) Morphometric quantification of lung sections shows a reduction in the intralveolar areas in infected mice compared to non-
infected controls (means 6 SD, n = 3–5). Significant differences were observed for the indicated groups (**p,0.01 and ***p,0.001). The data are
representative of three separate experiments.
doi:10.1371/journal.ppat.1004188.g003
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virulence explains the dichotomy concerning the protective and
deleterious roles of P2X7R in pulmonary TB.
Discussion
The development of two experimental mouse models of human-
like severe TB allowed us to determine the general properties of
phylogenetically distant strains of hypervirulent mycobacteria that
are associated with poor prognosis. The ability of Beijing 1471 Mtb
and MP287/03 Mbv to rapidly grow in the lungs, to cause
pulmonary necrosis and to disseminate to other organs likely
contributed to the worsening of the disease in C57BL/6 mice.
These data emphasize the importance of the mycobacterial genetic
background in the pathogenesis of severe TB and corroborate
previous studies in mice that showed significant variability in the
bacillus virulence of Mtb strains that were isolated from TB
Figure 4. Lung infiltrating cells and cytokine production in C57BL/6 and P2X7R2/2 mice on day 28 p.i. with hypervirulent
mycobacteria. C57BL/6 and P2X7R2/2 mice were infected i.t. with approx. 100 bacilli of H37Rv Mtb, Beijing 1471 Mtb and MP287/03 Mbv. Non-
infected mice were used as controls. (A) The numbers of total, CD11b+, CD19+, CD4+ and CD8+ cells in the lungs are shown (means6 SD, n = 3). (B) IL-
1b, IFNc and IL-10 were quantified in the supernatants of lung cells after 48 h of culture (means6 SD, n = 3). Significant differences were observed for
the indicated groups (*p,0.05, **p,0.01 and ***p,0.001). The data are representative of three separate experiments.
doi:10.1371/journal.ppat.1004188.g004
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patients [19,18,48,49] or Mbv strains that were isolated from
infected cattle [19,48,49]. Additionally, the comparison of the
disease progression in C57BL/6 and P2X7R2/2 mice that were
infected i.t. with a low inoculum (approx. 100 bacilli) of H37Rv
Mtb, Beijing 1471 Mtb and MP287/03 Mbv allowed us to describe
the crucial role of P2X7R in the aggressive forms of pulmonary
TB. These findings provide a new insight into the pathogenesis of
severe TB by showing that mice that lack P2X7R have attenuated
disease with substantially reduced bacillus burdens in the lungs,
livers and spleens. The absence of P2X7R also promoted
significant reductions in pneumonia and lung necrosis on day 28
p.i. with Beijing 1471 Mtb and MP287/03 Mbv, which corrobo-
rates our hypothesis of DAMP involvement in the pathogenesis of
severe TB. Furthermore, our data are consistent with a previous
study in P2X7R2/2 mice that reported no role for P2X7R during
pulmonary H37Rv Mtb infection [39].
P2X7R signaling could detrimentally affect the outcome of
severe TB by inducing the production of IL-1b and exacerbating
the pulmonary influx of pathogen-permissive monocytes and
macrophages. A recent study has implicated the recruitment of
CD11b+F4/80+Gr1int myeloid cells to the lungs in the exacerba-
tion of H37Rv Mtb infection in mice treated with Poly-IC [12].
Accordingly, our data link the reduction in the pulmonary
infiltration of CD11b+ myeloid cells with disease attenuation in
P2X7R2/2 mice that were infected with Beijing 1471 Mtb and
MP287/03 Mbv strains. The lack of P2X7R during the Beijing
1471 Mtb infection also resulted in lower IL-1b production by lung
infiltrating cells, which could have been responsible for the
secretion of less IFNc and more IL-10. Previous studies showing
the resistance of hypervirulent mycobacteria to IFNc-mediated
intracellular killing [37,38] may explain the ineffectiveness of IL-
1b, a critical cytokine in the protection against H37Rv Mtb [41], in
preventing the fatal outcome of the disease in Beijing 1471 Mtb-
infected C57BL/6 mice. Nevertheless, the induction of IL-1b does
not fully explain how P2X7R contributes to exacerbate the disease
progression during MP287/03 Mbv infection. In this case, severe
Figure 5. Induction of necrotic cell death and the release of bacteria and IL-1b in P2X7R2/2 and C57BL/6 BMDMs infected with
hypervirulent mycobacteria. C57BL/6 and P2X7R2/2 BMDMs were infected with H37Rv Mtb, Beijing 1471 Mtb and MP287/03 Mbv at an MOI of 10.
(A) On day 4 p.i., necrotic cells were identified by AO/EthBr incorporation. (B) Images show C57BL/6 and P2X7R2/2 BMDMs on day 4 p.i. with Beijing
1471 Mtb (2006 magnification; bar scales correspond to 100 mm). (C) The release of mycobacteria was examined by CFU quantification in the
supernatants of the infected cultures described in A. (D) On day 3 p.i., IL-1b was quantified in the culture supernatants. Significant differences were
observed for the indicated experimental conditions (***p,0.001). The data represent the means 6 SD of samples in triplicate. The data are
representative of three separate experiments.
doi:10.1371/journal.ppat.1004188.g005
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TB occurred concomitantly with a relatively high secretion of IL-
10 and low secretion of IL-1 b and IFNc, which correlated with
low numbers of CD4+ and CD8+ T cells in the lungs. In fact, we
have recently shown that MP287/03 Mbv-infected C57BL/6
macrophages are biased towards an M2 immune response profile
and induce higher arginase-1 expression and reduced NO
Figure 6. Effects of eATP on mycobacterial killing or release by C57BL/6 and P2X7R2/2 BMDMs. C57BL/6 and P2X7R2/2 BMDMs were
infected with H37Rv Mtb, Beijing 1471 Mtb and MP287/03 Mbv at an MOI of 10; treated with 0, 1 or 5 mM eATP for 30 min; and analyzed 6 h later. (A)
Mycobacterial killing was evaluated by intracellular CFU quantitation. (B) The release of mycobacteria from necrotic cells was examined by CFU
quantification in the culture supernatants. (C) Images show BMDM cultures (2006magnification; bar scales correspond to 100 mm). Significant
differences were observed between eATP-treated and non-treated groups and for the indicated experimental conditions (*p,0.05, **p,0.01 and
***p,0.001). The data represent the means 6 SD of samples in triplicate. The data are representative of three separate experiments.
doi:10.1371/journal.ppat.1004188.g006
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production compared to H37Rv Mtb-infected macrophages [38].
The inhibition of innate immune responses was also described for
other mycobacterial strains [18,50,51], and it has been considered
to be a selective advantage of modern mycobacterial strains that
contributes to rapid disease progression and transmission [51].
Furthermore, the lack of the P2X7R during MP287/03 Mbv
infection did not affect the low production of IL-1b by lung
infiltrating cells, but it restored the CD4+ and CD8+ T cell
responses with the secretion of more IFNc and less IL-10.
An alternative insight into the mechanism responsible for the
prejudicial role of P2X7R during severe TB was provided by the in
vitro analysis of C57BL/6 and P2X7R2/2 macrophages that were
infected with the H37Rv Mtb, Beijing 1471 Mtb and MP287/03
Mbv strains. The abilities of hypervirulent mycobacteria to rapidly
grow in C57BL/6 mice and to cause pulmonary necrosis were
associated with the abilities to multiply vigorously within C57BL/6
macrophages in vitro and to induce cell death. These findings show
a parallel between the in vivo and in vitro behavior of the
mycobacterial strains as reported in other studies [37,52]. In a
recapitulation of the in vivo data, only Beijing 1471 Mtb elicited the
production of high levels of IL-1b in C57BL/6 macrophages, but
both hypervirulent mycobacteria strains induced cell death. The
subsequent release of live bacilli and the negative staining for
annexin V clearly establish that these infected macrophages
undergo necrotic cell death. Therefore, with consideration for the
critical role of the NLRP3 inflammasome in Mtb-induced necrotic
death [53], it is likely that signaling through P2X7R accelerates
this process in C57BL/6 macrophages that are infected with
Beijing 1471 Mtb and MP287/03 Mbv. Accordingly, the absence of
the P2X7R led to a delay in macrophage death that was
accompanied by lower release of hypervirulent mycobacteria.
This finding indicates that P2X7R cooperates with mycobacterial
components exhibiting membrane-lysing activity, such as the
ESAT-6 protein from Mtb [54], a phenomenon that may occur
through autocrine or paracrine ATP release. The membrane
permeabilization that results as a secondary effect of P2X7R-
mediated necrotic death might also have facilitated the release of
IL-1b during the Beijing 1471 Mtb infection in C57BL/6
macrophages [55], as this response was partially inhibited in
P2X7R2/2 macrophages. Thus, even if P2X7R-mediated mac-
rophage death is an evolutionarily selected mechanism of host
defense, in Beijing 1471 Mtb and MP287/03 Mbv infections, it
allows the bacilli to escape from the innate host defenses and to
spread to new cells. A similar behavior was recently described for
mycobacteria that possess RD-1 virulence factors, which permit
phagolysosomal rupture and allow access to the cytosol [56].
The deleterious role of P2X7R during severe TB implies that
hypervirulent mycobacteria are resistant to the protective mech-
anisms that are elicited in macrophages following eATP stimula-
tion. In avirulent BCG infection, the engagement of the P2X7R
promotes phagosome-lysosome fusion and induces macrophage
apoptosis, thereby causing mycobacterial death [42,43,44].
Accordingly, macrophages from subjects homozygous for loss-of-
function P2X7R polymorphisms exhibit ablated eATP-induced
apoptosis and eATP-mediated killing of BCG bacilli [45,46]. In
fact, our data clearly establish that eATP stimulation has opposite
outcomes in macrophages that are infected with virulent or
hypervirulent mycobacteria. Thus, eATP induced the P2X7R-
mediated killing of H37Rv Mtb bacilli and the P2X7R-mediated
release of viable Beijing 1471 Mtb and MP287/03 Mbv bacilli. The
resistance of these hypervirulent mycobacteria to intracellular
killing has also been described following macrophage stimulation
with IFNc [37,38] and can be attributed to the ability of
pathogenic mycobacteria to block phagosome-lysosome fusion
[57]. The moderate extent of tissue damage with consequently
small amounts of eATP release and the susceptibility to eATP-
induced intracellular killing explain, respectively, the lack of
involvement or the protective role of P2X7R during the H37Rv
Mtb infection [39,40]. Finally, several epidemiological studies
reported that loss-of-function polymorphisms in the human
P2X7R gene increase the risk of pulmonary TB
[58,59,60,61,62]. However, opinions on this issue have not
reached a consensus, and other studies show a lack of association
between these parameters [63,64]. In sum, we can envisage that
the heterogeneity of the samples analyzed in these studies may
account for the failure to reach a consistent conclusion. Namely,
the risk of pulmonary TB in individuals with loss-of-function
polymorphisms in the P2X7R gene may be increased for mild TB
and decreased for severe TB. The protective role of the P2X7R
functional deficiency in the aggressive forms of TB could explain
why evolutionary pressure has maintained these gene polymor-
phisms at high rates in the human population.
The data from two mouse models indicated P2X7R as a key
molecule in the development of severe TB and suggested that lung
necrosis is enhanced by the activation of this receptor. P2X7R
appears to have a dual role in the development of aggressive TB.
First, it might facilitate the dissemination of hypervirulent
mycobacteria by inducing the lysis of infected macrophages.
Second, it might contribute to pneumonia and lung necrosis by
promoting widespread cell destruction. Based on these results, we
propose that the massive destruction of macrophages by hyper-
virulent mycobacteria with the help of the P2X7R leads to the
release of large amounts of ATP (Figure 7). This release triggers a
vicious cycle in which eATP exacerbates the pulmonary influx of
pathogen-permissive monocytes and macrophages [12] and leads
to further cell destruction by a P2X7R-mediated mechanism. This
scenario is made worse by the resistance of hypervirulent
mycobacteria to the protective mechanisms elicited in macro-
phages by eATP. The suppressive environment that results from
an excess of adenosine, a byproduct of eATP degradation, may
also facilitate the survival of hypervirulent mycobacteria [23]. This
study provides a perspective for the development of new
therapeutic approaches in which drugs designed to inhibit the




Male 8- to 10-week-old C57BL/6 and P2X7R2/2 (C57BL/6
background) mice (originally from the Jackson Laboratory, USA)
were bred under specific pathogen-free conditions at the Isogenic
Mice Facility (ICB/USP, Brazil). The P2X7R2/2 mice were
generated by Pfizer Inc. (USA) and backcrossed to C57BL/6 mice
for 7 generations; a single nucleotide polymorphism panel analysis
throughout the genome suggested a C57BL/6 genetic background
(http://jaxmice.jax.org/strain/005576.html). Once infected, the
experimental groups were maintained in microisolator cages at the
Biosafety Level 3 Mice Facilities (UENF and FCT-USP, Brazil)
under controlled temperature and humidity and were fed ad
libitum.
Ethics statement
All experimental procedures were conducted in accordance
with the national regulations on ethical guidelines for mouse
experimentation and welfare of the Conselho Nacional de Sau´de
and Cole´gio Brasileiro de Experimentac¸a˜o Animal (COBEA,
Brazil). The protocols were approved by the Animal Care
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Committee of ICB-USP and UENF under the permit numbers
0026/2009 and 0020/2006, respectively.
Mycobacteria
The Mtb strain of the Beijing genotype (Beijing 1471) was
isolated from a TB patient at the St. Petersburg Physiopulmonol-
ogy Research Institute, Russia [37]. Dr. Jose´ Soares Ferreira Neto
(Instituto de Medicina Veterina´ria, USP) and Dr. Philip Suffys
(Fundac¸a˜o Oswaldo Cruz, Brazil) kindly provided the bovine Mbv
isolate (MP287/03 - SB0295 spoligotyping) and the Mtb reference
strain (H37Rv - ATCC), respectively. Mycobacteria from a single
colony-forming unit (CFU) were suspended in Middlebrook 7H9
medium (Difco, BD Biosciences, USA) that was supplemented
with 10% albumin-dextrose-catalase (ADC) (Difco) and 0.05%
Tween 80 (Sigma-Aldrich, USA), with (for Mbv) or without (for
Mtb) 0.4% sodium pyruvate (Sigma-Aldrich), and were frozen at2
80uC in aliquots of 108 bacilli/ml. Prior to performing the
experiments, the aliquots were thawed, diluted in complete 7H9
medium, sonicated and incubated at 37uC for 7 days. To avoid
bacterial clumps, the aliquots were sonicated for 1 min, homog-
enized and kept at rest for 10 min at room temperature (RT). The
suspensions were collected, and the absence of bacterial clumps
was monitored by microscopic examination. The bacilli were
quantified by spectrophotometry at 600 nm.
CFU counting
The live bacterial burdens were determined by serial dilutions
and the plating of cell or tissue homogenates in Middlebrook 7H10
medium (Difco), which was supplemented with 10% oleic acid/
albumin/dextrose/catalase (OADC) (Difco); 0.4% sodium pyru-
vate was added for the Mbv strains. CFU numbers were
determined after a 3 week incubation at 37uC.
Mouse infections
Mice were anesthetized by intraperitoneal injections of
ketamine (Vetbrands, Brazil; 100 mg/kg) and xylazine (Vetbrands;
15 mg/kg), which were diluted in sterile saline. For each mouse,
the trachea was exposed via a small midline incision, and 60 ml of
Figure 7. Schematic illustration of a hypothetical model to explain the high and low involvement of the P2X7R during severe and
mild TB. In severe TB, the rapid intracellular growth of hypervirulent mycobacteria results in massive macrophage damage. The eATP released by
damaged cells may engage the P2X7R on their surfaces or on neighboring cells. The autocrine or paracrine P2X7R signaling cooperates with
mycobacterial components exhibiting membrane-lysing activity and accelerates the necrotic death of infected macrophages and the spread of bacilli.
The resistance of hypervirulent mycobacteria to the protective mechanisms elicited in macrophages by eATP contributes to disease dissemination.
The release of large amounts of eATP triggers a vicious cycle that exacerbates the pulmonary recruitment of pathogen-permissive monocytes and
macrophages and thereby leads to further intracellular bacillus growth. The suppressive environment that results from an excess of adenosine, a
byproduct of eATP degradation, may also facilitate the survival of hypervirulent mycobacteria. According to this model, lung necrosis derives from
programmed cell death that is triggered by P2X7R signaling. The modest levels of tissue damage induced by less virulent strains and the
susceptibility of these mycobacteria to eATP-induced intracellular killing explain, respectively, the minor role and the protective effect of the P2X7R in
the mild forms of TB.
doi:10.1371/journal.ppat.1004188.g007
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the bacterial suspension (approx. 100 bacilli) was inoculated
intratracheally (i.t.) [65]. The incision was sutured with sterile silk.
The inoculum dose was confirmed by a CFU count of lung
homogenates at 24 h p.i. and varied 620% in relation to the dose
of infection.
Macroscopic and microscopic analyses of the lungs, liver
and spleen
The relative mass (organ weight in infected mice/control mice)
of each organ was determined. Tissue samples from the right lung,
liver and spleen were fixed with 10% buffered formalin,
photographed and embedded in paraffin. Serial 4–5-mm sections
were stained with hematoxylin-eosin (HE) dye to analyze the tissue
alterations and by the Ziehl-Neelsen (ZN) method to detect
BAARs. The samples were examined with a Leica microscope
(Germany), and images were captured with a Coolpix P995 Nikon
camera (Japan).
Morphometric analysis of lung tissues
The percentages of the lung tissue occupied by intralveolar
space were determined as previously reported for intravascular
space in the placenta [66]. Briefly, 8 randomly selected images
were analyzed in each HE-stained section of lung tissue (506
magnification). Using ImageJ software (National Institutes of
Health, USA), the images were transformed in gray scale (8-bit)
and the areas corresponding to intralveolar space were colored in
red. The reduction in the percentages of intralveolar area was
calculated by the equation (x–y)*100/x, where x and y are,
respectively, the percentages of pixels covered by red areas in the
images of non-infected and infected mice.
Isolation of lung infiltrating cells
The left lungs were washed with sterile PBS and placed in Petri
dishes with RPMI 1640 medium (Gibco, USA). The dissected lung
tissue was incubated in medium that contained Liberase (Sigma-
Aldrich; 2 mg/ml) and type IV bovine pancreatic DNAse (Roche
Diagnostic; 1 mg/ml) at 37uC for 45 min. Cells were dispersed
with a 10-ml syringe (BD Biosciences) that was fitted with an 18-
gauge needle and filtered with a cell strainer (Corning, USA). Red
blood cells were depleted with a lysis buffer (0.144 M NH4Cl,
0.0169 M TRIS base, pH 7.4) at 37uC in a 5% CO2 atmosphere
for 5 min.
Phenotypic analysis of lung infiltrating cells
Lung infiltrating cells (16106) were stained using appropriate
combinations of Pacific Blue-, APC-Cy7-, PE-Cy7-, PE- or V500-
labeled monoclonal antibodies (mAbs) to CD11b (ICRF44),
CD19 (1D3), CD4 (RM4-5) and CD8 (53-6.7) (BD Pharmingen,
USA). Cells were fixed with 2% paraformaldehyde and analyzed
by flow cytometry (FACSCanto, BD Biosciences) with FlowJo
software.
Cytokine quantification
The lung infiltrating cells (56104 cells/well) were suspended in
complete RPMI 1640 medium (Gibco) with 1 mM sodium
pyruvate, 2 mM glutamine, 0.05% gentamicin and 10% fetal calf
serum (FCS) and were cultured in 96 well-plates (Corning) at 37uC
in a 5% CO2 atmosphere for 48 h. Cell culture supernatants were
harvested, filter sterilized and stored at 280uC. The levels of IL-
1b, IFNc and IL-10 in the cell culture supernatants were measured
with a Fluorokine kit (R&D System, USA) and a Bioplex system
(Bio-Rad, USA).
BMDM generation
BMDMs were generated from mouse femurs as described
previously [43], with some modifications. The two femurs were
each flushed with 5 ml of complete DMEM-F12 medium (Gibco;
1 mM sodium pyruvate, 2 mM glutamine, 0.05% gentamicin and
10% FCS) and were incubated at 37uC in a 5% CO2 atmosphere
for 12 h. Non-adherent cells were harvested and cultured for an
additional 3 days in a cell culture flask (Corning; 75 cm2) that
contained 10 ml of complete DMEM-F12 medium that was
supplemented with 20% L929 cell-conditioned medium as a
source of macrophage colony-stimulating factor. After 3 days, an
additional 10 ml of L929 cell-conditioned medium was added.
Four days later, BMDMs were detached from the flasks with 4 ml
of 2 mM trypsin in PBS. The viability of BMDMs was higher than
95% over a week period and decreased thereafter.
BMDM infection and eATP stimulation
The in vitro experiments were performed in a time window of 6
days after macrophage differentiation. BMDMs (46104 cells) were
cultured in 96-well plates in DMEM-F12 medium with 2% FCS at
37uC in a 5% CO2 atmosphere. To evaluate intracellular bacterial
growth, BMDMs were infected at an MOI of 1 for 3 h. After
washing 3 times with PBS, the intracellular bacteria were
evaluated by performing CFU counts of BMDMs that were lysed
with 0.1% saponin (Sigma-Aldrich) for 10 min. To analyze the
cytotoxicity induced by the bacteria, BMDMs were infected and
cellular viability was determined by acridine orange and ethidium
bromide (AO/EthBr; Sigma-Aldrich) incorporation using an
inverted NIKON TS-100 fluorescence microscope (Japan). To
establish the best experimental condition with which to discrim-
inate the differences between experimental groups, the cellular
viabilities were systematically determined at MOIs of 10 and 20.
The effects of eATP on bacterial intracellular killing and release
were assessed as previously described [45,46,47]. Briefly, BMDMs
were infected at an MOI of 10, washed 3 times with PBS and
stimulated with 1 or 5 mM eATP (Sigma-Aldrich) for 30 min. The
intracellular and extracellular CFU counts were determined after
6 h in culture. The cytotoxicity induced by eATP in non-infected
BMDMs was determined after 24 h in culture with 1 or 5 mM
eATP. The cells were stained with AO/EthBr and analyzed in an
inverted NIKON TS-100 fluorescence microscope.
Annexin V staining
BMDMs (46104 cells) were infected at an MOI of 10, washed 3
times with PBS and cultured for 4 days in 96-well plates in
DMEM-F12 medium with 2% FCS at 37uC in a 5% CO2
atmosphere. Non-infected BMDMs were stimulated with actino-
mycin D (Sigma-Aldrich; 2.5 mg/ml) for 6 h as a positive control
for apoptosis and with eATP (5 mM) for 24 h as a positive control
for necrosis. BMDMs were stained with FITC-labeled annexin V
[67] diluted in annexin binding buffer (10 mM HEPES, 150 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2) for 20 min and
then stained with propidium iodide (PI; Sigma-Aldrich; 1.6 mg/
ml). The samples were analyzed in an inverted NIKON TS-100
fluorescence microscope.
Statistical analysis
Statistical analyses were performed with the GraphPad Prism 4
software (GraphPad, USA), and the differences between the
groups were considered significant when p,0.05 (5%). The
simultaneous effects of two factors were analyzed by two-way
ANOVA and the Bonferroni post-hoc test. One-way ANOVA and
the Tukey post-hoc test were used to assess the effects of only one
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parameter. Survival curves were analyzed with the log-rank test of
the Kaplan-Meier method.
Supporting Information
Figure S1 Kinetics of intracellular bacillus growth and
macrophage necrosis in P2X7R2/2 and C57BL/6
BMDMs infected with hypervirulent mycobacteria.
C57BL/6 and P2X7R2/2 BMDMs were infected with H37Rv
Mtb, Beijing 1471 Mtb and MP287/03 Mbv at an MOI of 1
(intracellular bacillus growth) or at an MOI of 20 (macrophage
necrosis). (A) On days 0, 3 and 6 p.i., intracellular bacillus growth
was assessed by CFU quantification. (B) Macrophage necrosis was
evaluated by AO/EthBr incorporation on days 0, 2, 4 and 6 p.i. at
an MOI of 20. Significant differences were observed between the
C57BL/6 and P2X7R2/2 BMDMs (**p,0.01 and ***p,0.001).
The data represent the means 6 SD of samples in triplicate. The
data are representative of three separate experiments.
(TIF)
Figure S2 Annexin V and PI staining in P2X7R2/2 and
C57BL/6 BMDMs infected with hypervirulent mycobac-
teria. C57BL/6 BMDMs were infected with H37Rv Mtb, Beijing
1471 Mtb and MP287/03 Mbv at an MOI of 10. Non-infected
BMDMs were stimulated with actinomycin D (2.5 mg/ml) for 6 h
as a positive control for apoptosis and with eATP (5 mM) for 24 h
as a positive control for necrosis. Photos show BMDM cultures
(2006magnification; bar scales correspond to 100 mm). The data
are representative of three separate experiments.
(TIF)
Figure S3 Extracellular ATP-induced necrosis in
C57BL/6 and P2X7R2/2 BMDMs. C57BL/6 and
P2X7R2/2 BMDMs were cultured for 24 h with 0, 1, 2, 3 and
5 mM eATP. Macrophage necrosis was determined by AO/EthBr
incorporation. Images show viable cells (stained with AO) in green
and dead cells with permeabilized membranes (stained with EthBr)
in red (2006magnification; bar scales correspond to 100 mm). The
data are representative of three separate experiments.
(TIF)
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